Peregrine Capital Management LLC Amicus Therapeutics, Inc. Transaction History

Peregrine Capital Management LLC

  • $3.18 Billion
  • Q3 2024

A detailed history of Peregrine Capital Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 744,801 shares of FOLD stock, worth $7.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
744,801
Previous 812,938 8.38%
Holding current value
$7.3 Million
Previous $8.06 Million 1.36%
% of portfolio
0.25%
Previous 0.24%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$9.55 - $12.09 $650,708 - $823,776
-68,137 Reduced 8.38%
744,801 $7.95 Million
Q2 2024

Jul 29, 2024
BUY
$9.04 - $11.75 $717,676 - $932,820
79,389 Added 10.82%
812,938 $8.06 Million
Q1 2024

Apr 26, 2024
BUY
$11.43 - $14.24 $1.47 Million - $1.83 Million
128,201 Added 21.18%
733,549 $8.64 Million
Q4 2023

Jan 26, 2024
SELL
$9.97 - $14.52 $1.23 Million - $1.79 Million
-123,337 Reduced 16.93%
605,348 $8.59 Million
Q3 2023

Oct 19, 2023
BUY
$11.78 - $13.86 $223,984 - $263,534
19,014 Added 2.68%
728,685 $8.86 Million
Q2 2023

Jul 26, 2023
SELL
$10.72 - $13.3 $931,492 - $1.16 Million
-86,893 Reduced 10.91%
709,671 $8.91 Million
Q1 2023

Apr 26, 2023
BUY
$10.91 - $13.54 $1.01 Million - $1.26 Million
92,697 Added 13.17%
796,564 $8.83 Million
Q4 2022

Jan 10, 2023
SELL
$9.89 - $12.7 $1.07 Million - $1.38 Million
-108,494 Reduced 13.36%
703,867 $8.59 Million
Q3 2022

Oct 26, 2022
BUY
$9.82 - $12.75 $313,817 - $407,451
31,957 Added 4.09%
812,361 $8.48 Million
Q2 2022

Jul 20, 2022
SELL
$6.23 - $11.12 $292,286 - $521,705
-46,916 Reduced 5.67%
780,404 $8.38 Million
Q1 2022

Apr 27, 2022
SELL
$7.89 - $12.48 $374,388 - $592,188
-47,451 Reduced 5.42%
827,320 $7.84 Million
Q4 2021

Jan 31, 2022
BUY
$9.82 - $12.44 $1.62 Million - $2.05 Million
164,919 Added 23.23%
874,771 $10.1 Million
Q3 2021

Nov 02, 2021
SELL
$8.74 - $11.84 $93,815 - $127,090
-10,734 Reduced 1.49%
709,852 $6.78 Million
Q2 2021

Aug 03, 2021
BUY
$8.71 - $10.72 $268,259 - $330,165
30,799 Added 4.47%
720,586 $6.95 Million
Q1 2021

May 11, 2021
BUY
$9.2 - $23.86 $174,514 - $452,600
18,969 Added 2.83%
689,787 $6.82 Million
Q4 2020

Jan 19, 2021
SELL
$13.47 - $24.89 $4.21 Million - $7.78 Million
-312,479 Reduced 31.78%
670,818 $15.5 Million
Q3 2020

Oct 20, 2020
SELL
$12.89 - $15.89 $40,203 - $49,560
-3,119 Reduced 0.32%
983,297 $13.9 Million
Q2 2020

Jul 30, 2020
SELL
$8.86 - $15.69 $2.42 Million - $4.29 Million
-273,691 Reduced 21.72%
986,416 $14.9 Million
Q1 2020

Apr 17, 2020
BUY
$6.63 - $11.16 $30,014 - $50,521
4,527 Added 0.36%
1,260,107 $11.6 Million
Q4 2019

Jan 16, 2020
BUY
$7.48 - $10.75 $9.39 Million - $13.5 Million
1,255,580 New
1,255,580 $12.2 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email